WaveMan
WaveMan · Company
QTEX · Qtrex Quantum Ltd.
> Search tickers & screens ⌘K
LIVE
← All companies

QTEX QTREX Quantum (QTEX) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0001837493
C-suite buying · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $322.6K priced

What the filings say about QTEX

Insiders, 180 days
-$218.1K net sold
2 buyers · 2 sellers · 0% of sales under a 10b5-1 plan

QTREX Quantum insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, QTREX Quantum Ltd. insiders sold a net $218.1K of stock across 11 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.

Insider
Filed
Shares
Value
Since filing
Director
BUY
2026-10-15 SEC
6,666
$10.0K
-14.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 0.9% of the 766,666 shares held after it.
  • 1 other insider bought within 30 days.
Insider activity: Director Parnes Tal bought about $10.0K of QTEX on Oct 15, 2026; 1 other insider bought within 30 days.
Chief Executive Officer
BUY
2026-10-13 SEC
14,093
$21.0K
-11.6%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Oct 9, 2026.
  • The trade is 100.0% of the 14,093 shares held after it.
  • 1 other insider bought within 30 days.
Insider activity: Chief Executive Officer Ben-Noon Dagi Shahar bought about $21.0K of QTEX on Oct 13, 2026; 1 other insider bought within 30 days.
Chief Executive Officer
BUY
2026-10-09 SEC
18,181
$30.4K
-18.4%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Sep 28, 2026.
  • The trade is 0.5% of the 3,664,314 shares held after it.
  • 1 other insider bought within 30 days.
Insider activity: Chief Executive Officer Ben-Noon Dagi Shahar bought about $30.4K of QTEX on Oct 9, 2026; 1 other insider bought within 30 days.
Chief Executive Officer
BUY
2026-09-29 SECtraded 2026-09-28
168,894
$119.5K
+89.1%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 4.6% of the 3,646,133 shares held after it.
  • 1 other insider bought within 30 days.
Insider activity: Chief Executive Officer Ben-Noon Dagi Shahar bought about $119.5K of QTEX on Sep 28, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days.
Chief Financial Officer
SELL
2026-06-02 SECtraded 2026-06-01
28,100
$98.3K
-38.9%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on May 29, 2026.
  • The trade is 3.2% of the 870,000 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: Chief Financial Officer Tehila Yafit sold about $98.3K of QTEX on Jun 1, 2026; 1 other insider sold within 30 days.
11 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 6 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$218.1K over 180 days
+$180.9K over 90 days
below 52% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
11.3% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
more than 93% of Medical Devices
What changed in the last 30 days
Oct 28Insider selling stopped: no sales in 90 days after 7 in the prior 90
Why it matters
The absence is the signal: 7 sales in one 90-day window and none in the next is a change of behaviour, not a filing.
Oct 15Director Parnes Tal bought $10.0K (Oct 15)
Oct 13Chief Executive Officer Ben-Noon Dagi Shahar bought $170.9K (3 trades, Sep 28 to Oct 13)

Watch QTEX

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+18.3%12M
-72%+13%+98%+183%2025-102025-122026-022026-042026-062026-082026-10 2026-05-29 · Yechezkely Hayon Daniella sold $150.0K2026-09-28 · Ben-Noon Dagi Shahar bought $119.5K2026-06-01 · Tehila Yafit sold $98.3K2026-05-28 · Tehila Yafit sold $45.0K2026-05-28 · Tehila Yafit sold $38.4K2026-05-27 · Tehila Yafit sold $33.0K2026-10-09 · Ben-Noon Dagi Shahar bought $30.4K2026-05-27 · Tehila Yafit sold $27.6K2026-10-13 · Ben-Noon Dagi Shahar bought $21.0K2026-10-15 · Parnes Tal bought $10.0K2026-05-29 · Tehila Yafit sold $6.7K
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns QTEX: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in QTEX

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

QTEX planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $218.1K sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

QTEX financials

Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122025-062024-122023-12
Revenue$289.0Kn/a$0$0
Gross profit$2.0Kn/a$0$0
Operating income-$13.6Mn/a-$11.3M-$12.1M
Net income-$13.2Mn/a-$11.1M-$11.3M
EPS (diluted)-0.45n/a-0.60-0.93
Operating cash flow-$9.9Mn/a-$9.4M-$9.7M
Cash$3.2M$2.1M$5.1M$5.0M
SEC XBRL, fiscal years, as known on 2026-10-28

QTEX Stock Sonar score 2/7 axes

Find similar shapesCompare
Insider conviction
61
Inputs
  • Net Form 4 buying (codes P and S), 180d-$218K · 47 pct, sector of 140
  • Insider buyers, 180d2 · 74 pct, sector of 142
Risk and compliance
27
Inputs
  • Short interest, % of float+8.7% · 27 pct, sector of 240
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
5 not measured: Profitability, Financial health, Growth, Institutional and government, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

QTEX filings, in plain words

Are QTREX Quantum insiders buying or selling QTEX?

In the 180 days to 2026-10-28, QTREX Quantum insiders were net sellers, a net $218.1K: $180.9K of purchases and $399.0K of sales reported on Form 4, by 2 buyers and 2 sellers.

Read the full summary

In the 180 days to 2026-10-28, QTREX Quantum insiders were net sellers of QTEX, a net $218.1K across purchases and sales reported on Form 4 by 2 buyers and 2 sellers. 2 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. None of the 7 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing